 On Wednesday, August 05, Collegium Pharmaceutical NASDAQ: COLL will release its latest earnings report. Benzingas report can help you figure out the ins and outs of the earnings release.Earnings and Revenue Sell-side analysts expect Collegium Pharmaceuticals EPS to be near 0.2 on sales of 74.40 million. In the same quarter last year, Collegium Pharmaceutical posted EPS of -0.140 on sales of 75.04 million. The Wall Street estimate would represent a 242.86 increase in the companys earnings. Heres how the Collegium Pharmaceuticals reported EPS has stacked up against analyst estimates in the past:Quarter Q1 2020 Q4 2020 Q3 2019 Q2 2019 EPS Estimate 0.37 -0.10 -0.15 -0.19 EPS Actual 0.01 -0.07 -0.18 -0.14 Revenue Estimate 77.08 M 73.33 M 74.46 M 75.82 M Revenue Actual 76.51 M 74.20 M 72.94 M 75.04 M Stock Performance Over the last 52-week period, shares are up 54.34. Given that these returns are generally positive, long-term shareholders can be satisfied going into this earnings release.Dont be surprised to see the stock move on comments made during its conference call. Collegium Pharmaceutical is scheduled to hold the call at 16:30:00 ET and can be accessed here: more from Benzinga Carvanas Earnings Outlook Earnings Outlook For 3D Systems Earnings Preview for FiservC 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. 